About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Baltimore | 454 Studies

Clinical Trials Prostate CancerBaltimore

Prostate Cancer Clinical Trials in Baltimore

Find 454 clinical trials for prostate cancer near Baltimore, Maryland. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Baltimore

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 454 trials

Active not recruitingAn Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)The purpose of this study is to compare the radiographic progression-free survival (rPFS) of apalutamide in combination with abiraterone acetate (AA) plus prednisone or…NCT02257736·Phoenix, Arizona and 172 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedOpen- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate CancerThe ProVent study is a randomized, open-label study designed to assess the efficacy of sipuleucel-T in reducing the progression of lower risk non-metastatic prostate cancer…NCT03686683·Gilbert, Arizona and 55 others

CompletedRadiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells and may be an effective treatment for prostate cancer.NCT00002602·Birmingham, Alabama and 227 others

CompletedImaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer RecurrenceA prospective, Phase 3, multi center, single-arm, imaging study investigating the safety and diagnostic performance of rhPSMA 7.3 (18F) Positron Emission Tomography (PET) ligand…NCT04186845·Birmingham, Alabama and 27 others

TerminatedUtility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance ImagingThis is a two-tiered pilot study in which there will be no randomization and no placebo treatment.NCT04698564·Baltimore, Maryland

CompletedVaccine Therapy in Treating Patients With Recurrent Prostate CancerThis phase II trial is studying how well vaccine therapy works in treating patients with recurrent prostate cancer.NCT00109811·Baltimore, Maryland

CompletedEvaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone LossThis is a phase 3, randomized, double-blind, placebo-controlled study to evaluate new or worsening lens opacifications in men with non-metastatic prostate cancer receiving…NCT00925600·Anaheim, California and 171 others

CompletedA Study of Definitive Therapy to Treat Prostate Cancer After ProstatectomyTo assess the safety of treating men with oligometastatic prostate cancer with the following therapy: (1st) Systemic chemo-hormonal therapy with up to 6-months (\~24 weeks) of…NCT03043807·Washington D.C., District of Columbia and 1 other

CompletedExternal-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other sources to damage tumor cells. Giving radiation therapy in different ways may kill more tumor cells.NCT00006365·Birmingham, Alabama and 253 others

WithdrawnBariatric Arterial Embolization for Men Starting Hormones for Prostate CancerThe standard of care for obese men starting Androgen deprivation therapy (ADT) is physician based dietary and exercise counseling.NCT04331717·Baltimore, Maryland

Active not recruiting177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate CancerA Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I\&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant…NCT05204927·Tucson, Arizona and 51 others

CompletedAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)This is a Phase 1, open-label, dose-escalation trial of avelumab \[antibody targeting programmed death ligand 1 (anti PD-L1)\] with consecutive parallel group expansion in…NCT01772004·Goodyear, Arizona and 73 others

RecruitingA Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationPhase 1 dose escalation and expansion study of CLSP-1025, a first-in-class HLA-A\*02:01 specific T cell engager (TCE) targeting solid tumors that harbor the p53 R175H mutation.NCT06778863·Scottsdale, Arizona and 20 others

CompletedGemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerThis randomized phase III trial studies gemcitabine hydrochloride, cisplatin, and bevacizumab to see how well they work compared with gemcitabine hydrochloride and cisplatin in…NCT00942331·Birmingham, Alabama and 872 others

TerminatedEffect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate CancerThe purpose of this study is to determine whether GTx 758 is effective in achieving and maintaining castrate testosterone levels in men with advanced prostate cancer.NCT01326312·Phoenix, Arizona and 35 others

No longer availableRadium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesThis study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC patients diagnosed with symptomatic bone…NCT01516762·Birmingham, Alabama and 59 others

TerminatedValproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate CancerRATIONALE: Valproic acid may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00670046·Baltimore, Maryland

TerminatedTo Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate CancerPhase 1b - To assess the safety/tolerability of VERU-111 and to determine the maximum tolerated dose of VERU-111 in patients with metastatic, castration resistant prostate cancer…NCT03752099·Golden, Colorado and 12 others

CompletedPhase 3 Study of Immunotherapy to Treat Advanced Prostate CancerThe purpose of this study is to determine if asymptomatic or minimally symptomatic patients with metastatic prostate cancer who have not received chemotherapy live longer when…NCT01057810·Anchorage, Alaska and 133 others

RecruitingA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasThe purpose of this open-label, first-in-human (FIH) trial is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of…NCT04104776·Tampa, Florida and 79 others

PreviousPage 7 of 23Next

Other Conditions in Baltimore

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma